Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 117

1.

Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.

Gaudet MM, Chanock S, Lissowska J, Berndt SI, Yang XR, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Sherman ME, Sutter TR, Garcia-Closas M.

Pharmacogenet Genomics. 2006 Aug;16(8):547-53.

PMID:
16847423
2.

CYP1B1 and predisposition to breast cancer in Poland.

Matyjasik J, Cybulski C, Masojć B, Jakubowska A, Serrano-Fernandez P, Górski B, Debniak T, Huzarski T, Byrski T, Gronwald J, Złowocka E, Narod SA, Scott R, Lubinski J.

Breast Cancer Res Treat. 2007 Dec;106(3):383-8. Epub 2007 Apr 26.

PMID:
17458695
3.

Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.

Gaudet MM, Chanock S, Lissowska J, Berndt SI, Peplonska B, Brinton LA, Welch R, Yeager M, Bardin-Mikolajczak A, Garcia-Closas M.

Cancer Res. 2006 Oct 1;66(19):9781-5.

4.

Cytochrome P450 1B1 gene polymorphisms and postmenopausal breast cancer risk.

Rylander-Rudqvist T, Wedren S, Granath F, Humphreys K, Ahlberg S, Weiderpass E, Oscarson M, Ingelman-Sundberg M, Persson I.

Carcinogenesis. 2003 Sep;24(9):1533-9. Epub 2003 Jul 4.

5.

Leu432Val polymorphism in CYP1B1 as a susceptible factor towards predisposition to primary open-angle glaucoma.

Bhattacharjee A, Banerjee D, Mookherjee S, Acharya M, Banerjee A, Ray A, Sen A; Indian Genome Variation Consortium, Ray K.

Mol Vis. 2008 May 8;14:841-50.

6.

Association of CYP1B1 haplotypes and breast cancer risk in Caucasian women.

Huang Y, Trentham-Dietz A, García-Closas M, Newcomb PA, Titus-Ernstoff L, Hampton JM, Chanock SJ, Haines JL, Egan KM.

Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1321-3. doi: 10.1158/1055-9965.EPI-08-0853. Epub 2009 Mar 17.

7.

Association of CYP1B1 gene polymorphisms with susceptibility to endometrial cancer: a meta-analysis.

Wang F, Zou YF, Sun GP, Su H, Huang F.

Eur J Cancer Prev. 2011 Mar;20(2):112-20. doi: 10.1097/CEJ.0b013e3283410193.

PMID:
21191305
8.

Variant alleles of the CYP1B1 gene are associated with colorectal cancer susceptibility.

Trubicka J, Grabowska-Kłujszo E, Suchy J, Masojć B, Serrano-Fernandez P, Kurzawski G, Cybulski C, Górski B, Huzarski T, Byrski T, Gronwald J, Złowocka E, Kładny J, Banaszkiewicz Z, Wiśniowski R, Kowalska E, Lubinski J, Scott RJ.

BMC Cancer. 2010 Aug 11;10:420. doi: 10.1186/1471-2407-10-420.

9.

Common variation in EMSY and risk of breast and ovarian cancer: a case-control study using HapMap tagging SNPs.

Benusiglio PR, Lesueur F, Luccarini C, McIntosh J, Luben RN, Smith P, Dunning A, Easton DF, Ponder BA, Pharoah PD.

BMC Cancer. 2005 Jul 19;5:81.

10.

CYP1B1 polymorphisms and susceptibility to prostate cancer: a meta-analysis.

Zhang H, Li L, Xu Y.

PLoS One. 2013 Jul 4;8(7):e68634. doi: 10.1371/journal.pone.0068634. Print 2013.

11.

Similarity in recombination rate and linkage disequilibrium at CYP2C and CYP2D cytochrome P450 gene regions among Europeans indicates signs of selection and no advantage of using tagSNPs in population isolates.

Pimenoff VN, Laval G, Comas D, Palo JU, Gut I, Cann H, Excoffier L, Sajantila A.

Pharmacogenet Genomics. 2012 Dec;22(12):846-57. doi: 10.1097/FPC.0b013e32835a3a6d.

PMID:
23089684
12.

A comprehensive analysis of common genetic variation in prolactin (PRL) and PRL receptor (PRLR) genes in relation to plasma prolactin levels and breast cancer risk: the multiethnic cohort.

Lee SA, Haiman CA, Burtt NP, Pooler LC, Cheng I, Kolonel LN, Pike MC, Altshuler D, Hirschhorn JN, Henderson BE, Stram DO.

BMC Med Genet. 2007 Dec 1;8:72.

13.

Polymorphisms in genes involved in the estrogen pathway and mammographic density.

Dumas I, Diorio C.

BMC Cancer. 2010 Nov 22;10:636. doi: 10.1186/1471-2407-10-636.

14.

Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer.

Bailey LR, Roodi N, Dupont WD, Parl FF.

Cancer Res. 1998 Nov 15;58(22):5038-41. Erratum in: Cancer Res 1999 Mar 15;59(6):1388.

15.

Association of functionally important polymorphisms in cytochrome P4501B1 with lung cancer.

Shah PP, Singh AP, Singh M, Mathur N, Mishra BN, Pant MC, Parmar D.

Mutat Res. 2008 Aug 25;643(1-2):4-10. doi: 10.1016/j.mrfmmm.2008.05.001. Epub 2008 May 15.

PMID:
18573508
16.

A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.

Han W, Kang D, Lee JE, Park IA, Choi JY, Lee KM, Bae JY, Kim S, Shin ES, Lee JE, Shin HJ, Kim SW, Kim SW, Noh DY.

Clin Cancer Res. 2005 Jul 1;11(13):4775-8.

17.

A comprehensive haplotype analysis of CYP19 and breast cancer risk: the Multiethnic Cohort.

Haiman CA, Stram DO, Pike MC, Kolonel LN, Burtt NP, Altshuler D, Hirschhorn J, Henderson BE.

Hum Mol Genet. 2003 Oct 15;12(20):2679-92. Epub 2003 Aug 27.

18.

Glaucoma-associated CYP1B1 mutations share similar haplotype backgrounds in POAG and PACG phenotypes.

Chakrabarti S, Devi KR, Komatireddy S, Kaur K, Parikh RS, Mandal AK, Chandrasekhar G, Thomas R.

Invest Ophthalmol Vis Sci. 2007 Dec;48(12):5439-44.

PMID:
18055790
19.

Tag SNPs detect association of the CYP1B1 gene with primary open angle glaucoma.

Burdon KP, Hewitt AW, Mackey DA, Mitchell P, Craig JE.

Mol Vis. 2010 Nov 4;16:2286-93.

20.

The CYP1B1_1358_GG genotype is associated with estrogen receptor-negative breast cancer.

Justenhoven C, Pierl CB, Haas S, Fischer HP, Baisch C, Hamann U, Harth V, Pesch B, Brüning T, Vollmert C, Illig T, Dippon J, Ko YD, Brauch H.

Breast Cancer Res Treat. 2008 Sep;111(1):171-7. Epub 2007 Oct 6.

PMID:
17922187
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk